SELLAS Life Sciences Group, Inc. SLS Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s operating cash flow?
- SELLAS Life Sciences Group, Inc. (SLS) reported operating cash flow of -$8.85M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s operating cash flow changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s operating cash flow increased by 2.5% year-over-year, from -$9.07M to -$8.85M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), SELLAS Life Sciences Group, Inc.'s operating cash flow has grown at a 2.2% compound annual growth rate (CAGR), from -$26.02M to -$28.39M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.